Management

In addition to the hands-on Board, the Management Team comprises:

Kevin Pfleger BA (Hons), MA, PhD

Chief Scientific Officer

A/Prof Kevin Pfleger is the Chief Investigator of the Dimerix-funded research program being carried out in the Laboratory for Molecular Endocrinology under agreement with WAIMR and the University of Western Australia. Kevin is one of the world’s foremost authorities on the use of bioluminescence resonance energy transfer (BRET) technologies to study G-protein coupled receptors. He has published the seminal review and protocol for BRET in Nature Methods and Nature Protocols respectively, as well as publishing a novel derivation of the BRET technology, termed eBRET, that now enables prolonged monitoring of protein-protein interactions in real-time over timescales not previously possible. Kevin is co-inventor of the GPCR-HIT technology assigned to Dimerix from the University of Western Australia.

Liddy McCall LLB, BJuris, BCom (Hons)

Business Development

Liddy is an Investment Director, Yuuwa Capital LP, a venture capital firm based in Western Australia.

Prior roles include director and co-founder of Tessitura Pty Ltd, a company commercialising early stage biotechnology companies. Tessitura supported the development of Dimerix from initial research conducted at the Western Australian Institute for Medical Research (WAIMR). Liddy’s experience includes drug development, transplantation and medical device projects. She is a co-founder and previous director of iCeutica Inc, which is commercialising a technology to reformulate drug compounds at the nano-scale. Prior roles include Associate Director, Corporate Advisory Group of Macquarie Bank where she completed numerous corporate transactions.